Sequent Scientific Limited (BOM: 512529)

Sequent Scientific Statistics

Total Valuation

Sequent Scientific has a market cap or net worth of INR 43.03 billion. The enterprise value is 47.75 billion.

Market Cap	43.03B
Enterprise Value	47.75B

Important Dates

The next estimated earnings date is Monday, November 4, 2024.

Earnings Date	Nov 4, 2024
Ex-Dividend Date	n/a

Share Statistics

Sequent Scientific has 249.17 million shares outstanding. The number of shares has increased by 0.45% in one year.

Shares Outstanding	249.17M
Shares Change (YoY)	+0.45%
Shares Change (QoQ)	+9.94%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	15.30%
Float	117.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.02
PB Ratio	5.99
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	869.57
EV / Sales	3.35
EV / EBITDA	40.05
EV / EBIT	88.55
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	68.40
Debt / EBITDA	4.09
Debt / FCF	n/a
Interest Coverage	1.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	2.82%
Revenue Per Employee	11.94M
Profits Per Employee	45,950
Employee Count	1,195
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +96.13% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+96.13%
50-Day Moving Average	147.79
200-Day Moving Average	129.80
Relative Strength Index (RSI)	70.31
Average Volume (20 Days)	256,815

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sequent Scientific had revenue of INR 14.27 billion and earned 54.91 million in profits. Earnings per share was 0.22.

Revenue	14.27B
Gross Profit	6.48B
Operating Income	539.22M
Pretax Income	130.34M
Net Income	54.91M
EBITDA	1.19B
EBIT	539.22M
Earnings Per Share (EPS)	0.22

Balance Sheet

The company has 724.43 million in cash and 4.88 billion in debt, giving a net cash position of -4.15 billion or -16.67 per share.

Cash & Cash Equivalents	724.43M
Total Debt	4.88B
Net Cash	-4.15B
Net Cash Per Share	-16.67
Equity (Book Value)	7.13B
Book Value Per Share	28.83
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 45.38%, with operating and profit margins of 3.78% and 0.38%.

Gross Margin	45.38%
Operating Margin	3.78%
Pretax Margin	0.91%
Profit Margin	0.38%
EBITDA Margin	8.36%
EBIT Margin	3.78%
FCF Margin	n/a

Dividends & Yields

Sequent Scientific does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.45%
Shareholder Yield	-0.45%
Earnings Yield	0.13%
FCF Yield	n/a

Stock Splits

The last stock split was on February 25, 2016. It was a forward split with a ratio of 5.

Last Split Date	Feb 25, 2016
Split Type	Forward
Split Ratio	5